サマリー

生物学的治療薬の世界市場 2023-2027 年
Technavioは、生物学的治療薬市場を監視しており、2022年から2027年の間に286.12億米ドルで成長し、予測期間中のCAGRは11.34%で加速すると予測しています。当レポートでは、生物学的治療薬市場について、全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、バイオシミラーの導入、慢性疾患や免疫疾患の発生率の増加、主要な生物製剤の特許失効などが牽引しています。
Technavioの生物学的治療薬市場は以下のようにセグメント化されています：
用途別
- 癌
- 感染症
- 自己免疫疾患
- その他
製品別
- 抗体医薬
- ワクチン
- 細胞治療
- 遺伝子治療
- その他
地域別構成比
- 北アメリカ
- 欧州
- アジア
- その他の地域(ROW)
本調査では、強力な研究開発パイプラインが、今後数年間の生物学的治療薬市場の成長を促進する主要な要因の1つであることを明らかにしています。また、生物学的製剤の標的治療メカニズムや、生物学的製剤の開発への投資の増加は、市場の大きな需要につながると考えられます。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細なイメージを提示します。生物学的治療薬市場に関する当レポートは、以下の分野をカバーしています：
- 生物学的治療薬市場のサイジング
- 生物学的治療薬市場の予測
- 生物学的治療薬市場の産業分析
Technavioの強固なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、AbbVie Inc.、Amgen Inc.、Apogenix AG、AstraZeneca Plc、Aurobindo Pharma Ltd. 、Baxter International Inc., Biocon Ltd., BioMarin Pharmaceutical Inc., Celltrion Healthcare Co.Ltd.、Eli Lilly and Co.、GangaGen Biotechnologies Pvt Ltd.、GlaxoSmithKline Plc、Johnson and Johnson Services Inc.、Merck and Co.Inc.、Novartis AG、Pfizer Inc.、Precision Biologics Inc.、Samsung Electronics Co.Ltd.、Sanofi SA、およびTubulis GmbHです。また、生物学的治療薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報を客観的に組み合わせて実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、以下をご覧ください - https://www.technavio.com/report/biologic-therapeutics-market-industry-analysis
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数のソースからのデータを調査、合成、総括する方法で、市場の詳細なイメージを提示します。業界の主要なインフルエンサーを特定することにより、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global biologic therapeutics market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global biologic therapeutics market 2017 - 2021 ($ billion)
o 4.2 Application Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
o 4.3 Product Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Cancer - Market size and forecast 2022-2027
o Exhibit 34: Chart on Cancer - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Cancer - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Cancer - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
o 6.4 Infectious diseases - Market size and forecast 2022-2027
o Exhibit 38: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
o 6.5 Autoimmune diseases - Market size and forecast 2022-2027
o Exhibit 42: Chart on Autoimmune diseases - Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Autoimmune diseases - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Autoimmune diseases - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Autoimmune diseases - Year-over-year growth 2022-2027 (%)
o 6.6 Others - Market size and forecast 2022-2027
o Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Application
o Exhibit 50: Market opportunity by Application ($ billion)
o Exhibit 51: Data Table on Market opportunity by Application ($ billion)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 52: Chart on Product - Market share 2022-2027 (%)
o Exhibit 53: Data Table on Product - Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 54: Chart on Comparison by Product
o Exhibit 55: Data Table on Comparison by Product
o 7.3 Antibody therapeutics - Market size and forecast 2022-2027
o Exhibit 56: Chart on Antibody therapeutics - Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Data Table on Antibody therapeutics - Market size and forecast 2022-2027 ($ billion)
o Exhibit 58: Chart on Antibody therapeutics - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Antibody therapeutics - Year-over-year growth 2022-2027 (%)
o 7.4 Vaccines - Market size and forecast 2022-2027
o Exhibit 60: Chart on Vaccines - Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Vaccines - Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Vaccines - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Vaccines - Year-over-year growth 2022-2027 (%)
o 7.5 Cell therapy - Market size and forecast 2022-2027
o Exhibit 64: Chart on Cell therapy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Cell therapy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Cell therapy - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Cell therapy - Year-over-year growth 2022-2027 (%)
o 7.6 Gene therapy - Market size and forecast 2022-2027
o Exhibit 68: Chart on Gene therapy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Data Table on Gene therapy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Chart on Gene therapy - Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Gene therapy - Year-over-year growth 2022-2027 (%)
o 7.7 Others - Market size and forecast 2022-2027
o Exhibit 72: Chart on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 75: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Product
o Exhibit 76: Market opportunity by Product ($ billion)
o Exhibit 77: Data Table on Market opportunity by Product ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 79: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 81: Chart on Geographic comparison
o Exhibit 82: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 83: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 87: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 91: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 99: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 France - Market size and forecast 2022-2027
o Exhibit 111: Chart on France - Market size and forecast 2022-2027 ($ billion)
o Exhibit 112: Data Table on France - Market size and forecast 2022-2027 ($ billion)
o Exhibit 113: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 115: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 116: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 117: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 118: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 119: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 121: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 123: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 124: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 125: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 126: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 127: AbbVie Inc. - Overview
o Exhibit 128: AbbVie Inc. - Product / Service
o Exhibit 129: AbbVie Inc. - Key news
o Exhibit 130: AbbVie Inc. - Key offerings
o 12.4 Amgen Inc.
o Exhibit 131: Amgen Inc. - Overview
o Exhibit 132: Amgen Inc. - Product / Service
o Exhibit 133: Amgen Inc. - Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 134: AstraZeneca Plc - Overview
o Exhibit 135: AstraZeneca Plc - Product / Service
o Exhibit 136: AstraZeneca Plc - Key news
o Exhibit 137: AstraZeneca Plc - Key offerings
o 12.6 Aurobindo Pharma Ltd.
o Exhibit 138: Aurobindo Pharma Ltd. - Overview
o Exhibit 139: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 140: Aurobindo Pharma Ltd. - Key offerings
o 12.7 Baxter International Inc.
o Exhibit 141: Baxter International Inc. - Overview
o Exhibit 142: Baxter International Inc. - Business segments
o Exhibit 143: Baxter International Inc. - Key news
o Exhibit 144: Baxter International Inc. - Key offerings
o Exhibit 145: Baxter International Inc. - Segment focus
o 12.8 Biocon Ltd.
o Exhibit 146: Biocon Ltd. - Overview
o Exhibit 147: Biocon Ltd. - Business segments
o Exhibit 148: Biocon Ltd. - Key offerings
o Exhibit 149: Biocon Ltd. - Segment focus
o 12.9 Celltrion Healthcare Co. Ltd.
o Exhibit 150: Celltrion Healthcare Co. Ltd. - Overview
o Exhibit 151: Celltrion Healthcare Co. Ltd. - Product / Service
o Exhibit 152: Celltrion Healthcare Co. Ltd. - Key offerings
o 12.10 Eli Lilly and Co.
o Exhibit 153: Eli Lilly and Co. - Overview
o Exhibit 154: Eli Lilly and Co. - Product / Service
o Exhibit 155: Eli Lilly and Co. - Key offerings
o 12.11 GlaxoSmithKline Plc
o Exhibit 156: GlaxoSmithKline Plc - Overview
o Exhibit 157: GlaxoSmithKline Plc - Business segments
o Exhibit 158: GlaxoSmithKline Plc - Key news
o Exhibit 159: GlaxoSmithKline Plc - Key offerings
o Exhibit 160: GlaxoSmithKline Plc - Segment focus
o 12.12 Merck and Co. Inc.
o Exhibit 161: Merck and Co. Inc. - Overview
o Exhibit 162: Merck and Co. Inc. - Business segments
o Exhibit 163: Merck and Co. Inc. - Key news
o Exhibit 164: Merck and Co. Inc. - Key offerings
o Exhibit 165: Merck and Co. Inc. - Segment focus
o 12.13 Novartis AG
o Exhibit 166: Novartis AG - Overview
o Exhibit 167: Novartis AG - Business segments
o Exhibit 168: Novartis AG - Key offerings
o Exhibit 169: Novartis AG - Segment focus
o 12.14 Pfizer Inc.
o Exhibit 170: Pfizer Inc. - Overview
o Exhibit 171: Pfizer Inc. - Product / Service
o Exhibit 172: Pfizer Inc. - Key news
o Exhibit 173: Pfizer Inc. - Key offerings
o 12.15 Precision Biologics Inc.
o Exhibit 174: Precision Biologics Inc. - Overview
o Exhibit 175: Precision Biologics Inc. - Product / Service
o Exhibit 176: Precision Biologics Inc. - Key offerings
o 12.16 Samsung Electronics Co. Ltd.
o Exhibit 177: Samsung Electronics Co. Ltd. - Overview
o Exhibit 178: Samsung Electronics Co. Ltd. - Business segments
o Exhibit 179: Samsung Electronics Co. Ltd. - Key news
o Exhibit 180: Samsung Electronics Co. Ltd. - Key offerings
o Exhibit 181: Samsung Electronics Co. Ltd. - Segment focus
o 12.17 Sanofi SA
o Exhibit 182: Sanofi SA - Overview
o Exhibit 183: Sanofi SA - Business segments
o Exhibit 184: Sanofi SA - Key news
o Exhibit 185: Sanofi SA - Key offerings
o Exhibit 186: Sanofi SA - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 187: Inclusions checklist
o Exhibit 188: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 189: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 190: Research methodology
o Exhibit 191: Validation techniques employed for market sizing
o Exhibit 192: Information sources
o 13.5 List of abbreviations
o Exhibit 193: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global biologic therapeutics market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Cancer - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Cancer - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Cancer - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Autoimmune diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Autoimmune diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Autoimmune diseases - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Autoimmune diseases - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Application ($ billion)
Exhibits51: Data Table on Market opportunity by Application ($ billion)
Exhibits52: Chart on Product - Market share 2022-2027 (%)
Exhibits53: Data Table on Product - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by Product
Exhibits55: Data Table on Comparison by Product
Exhibits56: Chart on Antibody therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Antibody therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Antibody therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Antibody therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Vaccines - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Vaccines - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Vaccines - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Vaccines - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Cell therapy - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Cell therapy - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Cell therapy - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Cell therapy - Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Gene therapy - Market size and forecast 2022-2027 ($ billion)
Exhibits69: Data Table on Gene therapy - Market size and forecast 2022-2027 ($ billion)
Exhibits70: Chart on Gene therapy - Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Gene therapy - Year-over-year growth 2022-2027 (%)
Exhibits72: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits74: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits75: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits76: Market opportunity by Product ($ billion)
Exhibits77: Data Table on Market opportunity by Product ($ billion)
Exhibits78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits79: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits81: Chart on Geographic comparison
Exhibits82: Data Table on Geographic comparison
Exhibits83: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on France - Market size and forecast 2022-2027 ($ billion)
Exhibits112: Data Table on France - Market size and forecast 2022-2027 ($ billion)
Exhibits113: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits115: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits116: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits117: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits118: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits119: Market opportunity By Geographical Landscape ($ billion)
Exhibits120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits121: Impact of drivers and challenges in 2022 and 2027
Exhibits122: Overview on Criticality of inputs and Factors of differentiation
Exhibits123: Overview on factors of disruption
Exhibits124: Impact of key risks on business
Exhibits125: Vendors covered
Exhibits126: Matrix on vendor position and classification
Exhibits127: AbbVie Inc. - Overview
Exhibits128: AbbVie Inc. - Product / Service
Exhibits129: AbbVie Inc. - Key news
Exhibits130: AbbVie Inc. - Key offerings
Exhibits131: Amgen Inc. - Overview
Exhibits132: Amgen Inc. - Product / Service
Exhibits133: Amgen Inc. - Key offerings
Exhibits134: AstraZeneca Plc - Overview
Exhibits135: AstraZeneca Plc - Product / Service
Exhibits136: AstraZeneca Plc - Key news
Exhibits137: AstraZeneca Plc - Key offerings
Exhibits138: Aurobindo Pharma Ltd. - Overview
Exhibits139: Aurobindo Pharma Ltd. - Product / Service
Exhibits140: Aurobindo Pharma Ltd. - Key offerings
Exhibits141: Baxter International Inc. - Overview
Exhibits142: Baxter International Inc. - Business segments
Exhibits143: Baxter International Inc. - Key news
Exhibits144: Baxter International Inc. - Key offerings
Exhibits145: Baxter International Inc. - Segment focus
Exhibits146: Biocon Ltd. - Overview
Exhibits147: Biocon Ltd. - Business segments
Exhibits148: Biocon Ltd. - Key offerings
Exhibits149: Biocon Ltd. - Segment focus
Exhibits150: Celltrion Healthcare Co. Ltd. - Overview
Exhibits151: Celltrion Healthcare Co. Ltd. - Product / Service
Exhibits152: Celltrion Healthcare Co. Ltd. - Key offerings
Exhibits153: Eli Lilly and Co. - Overview
Exhibits154: Eli Lilly and Co. - Product / Service
Exhibits155: Eli Lilly and Co. - Key offerings
Exhibits156: GlaxoSmithKline Plc - Overview
Exhibits157: GlaxoSmithKline Plc - Business segments
Exhibits158: GlaxoSmithKline Plc - Key news
Exhibits159: GlaxoSmithKline Plc - Key offerings
Exhibits160: GlaxoSmithKline Plc - Segment focus
Exhibits161: Merck and Co. Inc. - Overview
Exhibits162: Merck and Co. Inc. - Business segments
Exhibits163: Merck and Co. Inc. - Key news
Exhibits164: Merck and Co. Inc. - Key offerings
Exhibits165: Merck and Co. Inc. - Segment focus
Exhibits166: Novartis AG - Overview
Exhibits167: Novartis AG - Business segments
Exhibits168: Novartis AG - Key offerings
Exhibits169: Novartis AG - Segment focus
Exhibits170: Pfizer Inc. - Overview
Exhibits171: Pfizer Inc. - Product / Service
Exhibits172: Pfizer Inc. - Key news
Exhibits173: Pfizer Inc. - Key offerings
Exhibits174: Precision Biologics Inc. - Overview
Exhibits175: Precision Biologics Inc. - Product / Service
Exhibits176: Precision Biologics Inc. - Key offerings
Exhibits177: Samsung Electronics Co. Ltd. - Overview
Exhibits178: Samsung Electronics Co. Ltd. - Business segments
Exhibits179: Samsung Electronics Co. Ltd. - Key news
Exhibits180: Samsung Electronics Co. Ltd. - Key offerings
Exhibits181: Samsung Electronics Co. Ltd. - Segment focus
Exhibits182: Sanofi SA - Overview
Exhibits183: Sanofi SA - Business segments
Exhibits184: Sanofi SA - Key news
Exhibits185: Sanofi SA - Key offerings
Exhibits186: Sanofi SA - Segment focus
Exhibits187: Inclusions checklist
Exhibits188: Exclusions checklist
Exhibits189: Currency conversion rates for US$
Exhibits190: Research methodology
Exhibits191: Validation techniques employed for market sizing
Exhibits192: Information sources
Exhibits193: List of abbreviations